跳至主要内容
临床试验/EUCTR2017-002724-25-DK
EUCTR2017-002724-25-DK进行中(未招募)1 期

Intravenous and oral paracetamol in neonates: safety and ethanol-drug interactions – the PARASHUTE Trial - PARASHUTE trial

Helle Holst0 个研究点目标入组 120 人开始时间: 2017年7月7日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Neonates any gestational age and weight of both genders
  • Post menstrual age up to 44 full weeks at inclusion
  • Intended treatment with i.v. paracetamol for any indication or intended treatment with p.o. paracetamol for one of the following indications: fractures, cranial haemorrhages, chest tubes, postoperative pain or painfull skin lessions.
  • Informed written consent from both parents or legal guardian, Informed Consents must be approved by the Danish Ethical Committee
  • Signing consent form can be postponed 24 hours after treatment start
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 120
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • The responsible clinicians finds the patient unsuitable for trial
  • Hypersensitivity towards paracetamol

研究者

发起方
Helle Holst

相似试验